Dosing strategy of tacrolimus when co-administered with Wuzhi tablet in renal transplant recipients

We establish a TAC PPK model comprising <i>Wuzhi</i> as a covariate in renal transplant recipients and recommend an initial dose of TAC when co-administered with <i>Wuzhi</i>, which could provide reference for the individualized regimens of TAC.

Authors

Publication Details

Journal
International Journal of Clinical Pharmacology and Therapeutics
Published
2024-08-19
DOI
https://doi.org/10.5414/cp204561
Primary Topic
Pharmacological Effects of Natural Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dosing strategy of tacrolimus when co-administered with Wuzhi tablet in renal transplant recipients

Qian Fu, Jun Li, Min Huang, Xiaoman Liu et al.
International Journal of Clinical Pharmacology and Therapeutics
Pharmacological Effects of Natural Compounds
article

Dosing strategy of tacrolimus when co-administered with Wuzhi tablet in renal transplant recipients

Qian Fu, Jun Li, Min Huang, Xiaoman Liu, Yiting Cai, Changxi Wang, Pan Chen, Rui Dai
article en

Abstract

We establish a TAC PPK model comprising <i>Wuzhi</i> as a covariate in renal transplant recipients and recommend an initial dose of TAC when co-administered with <i>Wuzhi</i>, which could provide reference for the individualized regimens of TAC.

International Journal of Clinical Pharmacology and TherapeuticsVol. 62(11)
Zero hunger
Openalex Percentile: Top 83%
Pharmacological Effects of Natural Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.